Cargando…
Understanding and Targeting Apoptotic Pathways in Ovarian Cancer
Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from external forces such as blunt trauma to programmed pr...
Autores principales: | Al-Alem, Linah F., Baker, Andrew T., Pandya, Unnati M., Eisenhauer, Eric L., Rueda, Bo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893837/ https://www.ncbi.nlm.nih.gov/pubmed/31652965 http://dx.doi.org/10.3390/cancers11111631 |
Ejemplares similares
-
Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
por: Bouberhan, Sara, et al.
Publicado: (2020) -
Galectins and Ovarian Cancer
por: Shimada, Chisa, et al.
Publicado: (2020) -
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
por: Jan, Rehmat, et al.
Publicado: (2019) -
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018) -
Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma
por: Eavarone, David A., et al.
Publicado: (2018)